Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank86
3Y CAGR+37.6%
5Y CAGR+122.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+37.6%/yr
Annual compound
5Y CAGR
+122.4%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
54.5x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.27 | -15.5% |
| 2024 | 0.32 | +110.4% |
| 2023 | 0.15 | +46.4% |
| 2022 | 0.10 | +823.6% |
| 2021 | 0.01 | +126.5% |
| 2020 | 0.01 | +118.3% |
| 2019 | -0.03 | - |
| 2018 | 0.00 | - |